Sembol | Vade sonu getirisi % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
---|---|---|---|---|---|---|---|---|---|
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 7,61% | 30 K | 72,85% | 4,35% | 2047-11-15 | 13,57 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
7,16% | 0 | 58,25% | 2,55% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,62% | 0 | 67,07% | 2,35% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,47% | 0 | 71,93% | 3,90% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,41% | 0 | 73,14% | 3,70% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,40% | 65 K | 90,24% | 5,25% | 2043-08-15 | 4,06 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,38% | 20 K | 84,86% | 4,63% | 2044-05-15 | 3,69 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,35% | 186 K | 74,29% | 3,25% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6,24% | 348 K | 88,78% | 5,00% | 2045-08-15 | 15,71 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,18% | 0 | 78,12% | 3,55% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,14% | 1,15 M | 81,45% | 4,25% | 2049-10-26 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,08% | 1,45 M | 83,51% | 4,35% | 2047-11-15 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,02% | 7,2 M | 85,85% | 4,55% | 2048-02-20 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,98% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,3 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
5,96% | 0 | 86,98% | 4,50% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,89% | 0 | 97,13% | 5,65% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,86% | 1,03 M | 88,84% | 4,63% | 2044-05-15 | 744,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,82% | 15 K | 94,89% | 5,25% | 2043-08-15 | 218,37 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,78% | 1,25 M | 87,01% | 4,13% | 2039-06-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,75% | 13,8 M | 92,94% | 5,00% | 2045-08-15 | 741,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,73% | 0 | 108,02% | 6,40% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,73% | 0 | 98,01% | 5,55% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,62% | 0 | 106,92% | 6,25% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,59% | 0 | 99,17% | 5,50% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,54% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,42 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
5,35% | 0 | 87,65% | 2,95% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,35% | 237 K | 82,85% | 1,45% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,33% | 50 K | 103,16% | 5,70% | 2040-10-15 | 151,01 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,31% | 0 | 104,07% | 5,88% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 30 K | 107,18% | 6,13% | 2038-05-01 | 219,25 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 0 | 99,96% | 5,20% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,12% | 980 K | 95,87% | 3,45% | 2027-11-15 | 16,55 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 5,11% | 50 K | 96,83% | 3,90% | 2028-02-20 | 43,84 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
5,06% | 0 | 105,07% | 5,90% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,93% | 0 | 100,79% | 5,10% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,90% | 1,44 M | 94,54% | 3,40% | 2029-07-26 | 2,37 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,87% | 0 | 104,07% | 5,75% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,76% | 0 | 100,48% | 4,90% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,68% | 0 | 97,34% | 3,25% | 2027-02-27 | 512,28 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,65% | 0 | 91,41% | 1,13% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,62% | 1,07 M | 98,10% | 3,90% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,62% | 146 K | 100,32% | 4,95% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,59% | 99 K | 99,64% | 3,88% | 2025-08-15 | 228,73 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,59% | 10 K | 103,59% | 6,80% | 2026-11-15 | 255,95 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
4,54% | 55 K | 97,34% | 3,45% | 2027-11-15 | 517,67 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,51% | 0 | 100,43% | 4,95% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,51% | 8 M | 98,36% | 3,20% | 2026-06-15 | 1,74 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,50% | 0 | 100,74% | 4,90% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,47% | 4,43 M | 97,31% | 0,75% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,42% | 0 | 87,31% | 1,75% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
3,03% | 0 | 99,50% | 1,00% | 2025-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,33% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,56 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |